When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PHAT - Phathom Pharmaceuticals names UroGen's Henderson as new CFO
Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals (NASDAQ:PHAT) stated Tuesday that it has appointed Molly Henderson as the company's new chief financial and business officer, effective Apr. 5, 2022. Henderson has most recently served as CFO of UroGen Pharma (URGN), and previously at Advaxis (OTC:ADXS). Currently, Henderson also serves as a board member and chair of the audit committee of Calliditas Therapeutics AB (CALT). Earlier this month, Phathom Pharmaceuticals GAAP EPS of -$0.95 beats by $0.05